首頁 > 市場調查報告書 > 製藥

以基因為基之藥物開發

市場調查報告書

商品編碼

1824207

全球基因組學市場預測（2025-2030）

Genomics Market - Forecasts from 2025 to 2030

出版日期: 2025年08月15日 | 出版商:

Knowledge Sourcing Intelligence | 英文 154 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

全球基因組學市場預計將從 2025 年的 359 億美元成長到 2030 年的 623.97 億美元，複合年成長率為 11.69%。

全球基因組學市場正經歷強勁成長，這得益於疾病（尤其是癌症）發病率的上升，以及政府和私營部門推動基因研究的舉措不斷增加。基因組學涵蓋重組DNA、DNA定序和生物資訊學，能夠分析生物體的整個基因組，並支持基因治療、個人化醫療和臨床研究的應用。市場對創新治療解決方案的需求以及行業參與者之間的合作推動了該市場的蓬勃發展。

市場促進因素

疾病發生率上升和癌症基因組學

疾病（尤其是遺傳性癌症）的日益普及是基因組學市場的主要驅動力。對人類基因組的深入了解正在推動利用 CRISPR-Cas 等技術治療癌症的先進基因療法的發展。癌症基因組學因其在識別基因突變、開發標靶治療以及改善治療效果和患者預後方面的潛力而日益成長。

政府和私部門的舉措

政府和私營部門的大量投資正在加速基因組學研究。例如，英國研發部於2022年12月撥款1.75億英鎊用於基因組學研究，以支持一項為期三年的計劃，旨在開發和部署尖端基因組醫學技術。這些旨在透過分析患者DNA來改善診斷和治療的舉措正在推動市場成長。同樣，製藥和生技公司也在大力投資藥物研發和個人化醫療，並透過創新的研發策略進一步推動市場發展。

共同努力和行業夥伴關係

產業聯盟、合資企業和收購正在推動基因組學市場的成長。這些夥伴關係促進了尖端技術的整合，並擴展了基因組學在診斷和精準醫療領域的應用範圍。高度重視合作研究可以促進創新，從而開發新的工具和平台來應對複雜的健康挑戰。

地理視角

北美洲

由於大型製藥公司和研究機構的集中，北美在全球基因組學市場佔據重要佔有率。該地區強大的基礎設施支持著人類基因組計劃和癌症基因組圖譜計劃等舉措，這些計劃推動了基因組學在疾病研究和治療開發中的應用。美國仍然保持領先地位，並因其對基因表現及其對健康結果的影響而推動市場擴張。

亞太地區

受疾病盛行率上升和對創新療法和診斷需求不斷成長的推動，亞太地區預計將實現高複合年成長率。政府和私營部門的舉措，例如大規模人類基因序列測定計劃，正在推動市場成長。該地區被定位為重要的成長中心，尤其是在中國和印度等致力於透過基因組學應對健康挑戰的國家。

市場趨勢

基因組學市場的特點是採用最尖端科技，例如用於基因編輯的 CRISPR-Cas 以及整合生物資訊學進行全面的基因組分析。個人化醫療和癌症基因組學日益成長的需求正在推動診斷和治療應用的創新。收購和合資企業等合作發展正在加強先進基因組平台的開發。此外，政府和私營部門對精準醫療和藥物研發的投入不斷增加，也與全球衛生優先事項一致。

受疾病（尤其是癌症）發病率上升以及政府和私營舉措的大力推動，基因組學市場預計將顯著成長。北美憑藉強大的製藥和研究生態系統處於領先地位，而亞太地區則由於診斷和治療需求的不斷成長而迅速擴張。先進的基因編輯、合作夥伴關係和創新工具的趨勢正在塑造市場的未來。隨著對個人化醫療和基因組醫療保健的日益關注，基因組學市場在預測期內應對關鍵健康挑戰的同時，已準備好實現持續擴張。

本報告的主要優點

深刻分析：獲得涵蓋主要和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、行業垂直領域和其他細分領域。
競爭格局：了解主要企業正在採取的策略舉措，並了解正確策略的市場滲透潛力。
市場趨勢和促進因素：探索動態因素和關鍵市場趨勢以及它們將如何影響未來的市場發展。
可行的建議：利用洞察力來制定策略決策，在動態環境中開闢新的業務流和收益。
受眾廣泛：對於新興企業、研究機構、顧問、中小企業和大型企業來說都是有益且具成本效益的。

報告的主要用途

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本支出決策、法律規範與影響、新產品開發、競爭影響

調查範圍

2022-2024年實際數據及2025-2030年預測數據
成長機會、挑戰、供應鏈前景、法規結構與趨勢分析
競爭定位、策略和市場佔有率分析
各地區（包括細分市場和國家）的收益成長和預測分析
公司簡介（主要包括策略、產品、財務資訊、主要發展動態等）

The global genomics market is experiencing robust growth, driven by the rising prevalence of diseases, particularly cancer, and increasing government and private initiatives to advance genetic research. Genomics, encompassing recombinant DNA, DNA sequencing, and bioinformatics, analyzes an organism's entire genome, supporting applications in gene therapy, personalized medicine, and clinical research. The market is propelled by the demand for innovative therapeutic solutions and collaborative efforts among industry players.

Market Drivers

Rising Disease Prevalence and Cancer Genomics

The increasing incidence of diseases, particularly inherited cancers, is a primary driver of the genomics market. The growing understanding of the human genome has spurred the development of advanced gene therapies, leveraging technologies like CRISPR-Cas for cancer treatment. The demand for cancer genomics is rising due to its potential to identify genetic variations and develop targeted therapies, enhancing treatment efficacy and patient outcomes.

Government and Private Initiatives

Significant government and private sector investments are accelerating genomics research. For instance, in December 2022, the UK Department of Health and Social Care allocated £175 million to fund genomics research, supporting a three-year plan to develop and implement cutting-edge genomic healthcare technologies. These initiatives aim to analyze patients' DNA to improve diagnostics and treatment, driving market growth. Similarly, pharmaceutical and biotechnology companies are investing heavily in drug discovery and personalized medicine, further boosting the market through innovative research and development strategies.

Collaborative Efforts and Industry Partnerships

Collaborations, joint ventures, and acquisitions among industry players are enhancing genomics market growth. These partnerships facilitate the integration of advanced technologies and expand the scope of genomic applications in diagnostics and precision medicine. The focus on collaborative research is fostering innovation, enabling the development of novel tools and platforms to address complex health challenges.

Geographical Outlook

North America

North America holds a significant share of the global genomics market, driven by its concentration of major pharmaceutical companies and research organizations. The region's robust infrastructure supports initiatives like the Human Genome Project and the Cancer Genome Atlas Program, which advance genomic applications in disease research and therapeutic development. The U.S. remains a leader due to its focus on genetic expression and its impact on health outcomes, supporting market expansion.

Asia-Pacific

The Asia-Pacific region is expected to grow at a high compound annual growth rate (CAGR), fueled by the rising prevalence of diseases and increasing demand for innovative therapeutic drugs and diagnostics. Government and private sector initiatives, such as large-scale human genome sequencing projects, are driving market growth. The region's focus on addressing health challenges through genomics, particularly in countries like China and India, positions it as a key growth hub.

Market Trends

The genomics market is characterized by the adoption of cutting-edge technologies like CRISPR-Cas for gene editing and the integration of bioinformatics for comprehensive genome analysis. The rising demand for personalized medicine and cancer genomics is driving innovation in diagnostic and therapeutic applications. Collaborative efforts, such as acquisitions and joint ventures, are enhancing the development of advanced genomic platforms. The market also benefits from increased government funding and private sector investment in precision medicine and drug discovery, aligning with global health priorities.

The genomics market is poised for significant growth, driven by the rising prevalence of diseases, particularly cancer, and robust government and private initiatives. North America leads due to its strong pharmaceutical and research ecosystem, while Asia-Pacific is set for rapid expansion with increasing demand for diagnostics and therapeutics. Trends toward advanced gene editing, collaborative partnerships, and innovative tools are shaping the market's future. As the focus on personalized medicine and genomic healthcare intensifies, the genomics market is well-positioned for sustained expansion, addressing critical health challenges during the forecast period.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2022 to 2024 & forecast data from 2025 to 2030
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Market Segmentation:

By Technology

PCR
Sequencing
Microarray
Nucleic Acid Extraction and Purification
Others

By Application

Drug Discovery and Development
Diagnostics
Precision Medicine
Agriculture and Animal Research
Other Applications

By End-User

Hospitals & Clinics
Research Centers & Government Institutes
Pharmaceutical & Biotechnology Companies
Others

By Geography

North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East And Africa
Saudi Arabia
Israel
Other
Asia Pacific
China
Japan
India
South Korea
Indonesia
Taiwan
Others

1. INTRODUCTION

1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Data
2.2. Sources
2.3. Research Design

3. EXECUTIVE SUMMARY

3.1. Research Highlights

4. MARKET DYNAMICS

4.1. Market Drivers
4.2. Market Restraints
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers
- 4.3.2. Bargaining Power of Buyers
- 4.3.3. Threat of New Entrants
- 4.3.4. Threat of Substitutes
- 4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. GLOBAL GENOMICS MARKET BY APPLICATION

5.1. Introduction
5.2. Drug Discovery and Development
5.3. Diagnostics
5.4. Precision Medicine
5.5. Agriculture and Animal Research
5.6. Other Applications

6. GLOBAL GENOMICS MARKET BY END-USER

6.1. Introduction
6.2. Hospitals & clinics
6.3. Research centers & Government Institutes
6.4. Pharmaceutical & Biotechnology Companies
6.5. Others

7. GLOBAL GENOMICS MARKET BY TECHNOLOGY

7.1. Introduction
7.2. PCR
7.3. Sequencing
7.4. Microarray
7.5. Nucleic Acid Extraction and Purification
7.6. Others

8. GLOBAL GENOMICS MARKET BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. USA
- 8.2.2. Canada
- 8.2.3. Mexico
8.3. South America
- 8.3.1. Brazil
- 8.3.2. Argentina
- 8.3.3. Others
8.4. Europe
- 8.4.1. Germany
- 8.4.2. France
- 8.4.3. United Kingdom
- 8.4.4. Spain
- 8.4.5. Others
8.5. Middle East And Africa
- 8.5.1. Saudi Arabia
- 8.5.2. Israel
- 8.5.3. Other
8.6. Asia Pacific
- 8.6.1. China
- 8.6.2. Japan
- 8.6.3. India
- 8.6.4. South Korea
- 8.6.5. Indonesia
- 8.6.6. Taiwan
- 8.6.7. Others